Dispensed by Prescription

cellulose, D&C Yellow #10, magnesium stearate, silicon dioxide, titanium dioxide.

Xvite Tablets is an orally administered prescription vitamin formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced folate, vitamin B supplementation, and maintenance of good health is needed.

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Xvite Tablets should only be used under the direction and supervision of a licensed medical practitioner.

Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking other medications.

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

You should call your doctor for medical advice about serious adverse events. To report adverse side effects or to obtain product information, contact Foxland Pharmaceuticals, Inc., Trussville, AL 35173.

Usual adult dose is 1 tablet once or twice daily or as prescribed by a licensed medical practitioner.

Xvite Tablets are supplied as light yellow oblong tablets debossed with "040" in a child-resistant bottle of 30ct (69067-040-30)

Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature.]

Protect from heat, light and moisture.

KEEP OUT OF THE REACH OF CHILDREN.

Tamper Evident: Do not use if seal is broken or missing.

Manufactured for:
Foxland Pharmaceuticals, Inc.
Trussville, AL 35173

Rev. 08/18

Dispensed by Prescription1

1

This product is a prescription-folate with or without other dietary ingredients that – due to increased folate levels increased risk associated with masking of B12 deficiency (pernicious anemia) requires administration under the care of a licensed medical practitioner (61 FR 8760).1-3 The most appropriate way to ensure pedigree reporting consistent with these regulatory guidelines and safety monitoring is to dispense this product only by prescription (Rx). This is not an Orange Book product. This product may be administered only under a physician's supervision and all prescriptions using this product shall be pursuant to state statutes as applicable. The ingredients, indication or claims of this product are not to be construed to be drug claims.

1. Federal Register Notice of August 2, 1973 (38 FR 20750)
2. Federal Register Notice of October 17, 1980 (45 FR 69043, 69044)
3. Federal Register Notice of March 5, 1996 (61 FR 8760)

69067-040-30

XVITE
Tablets

Dietary Supplement

Dispensed by Prescription

30 Tablets

Foxland
PHARMACEUTICALS, INC.